Status:
COMPLETED
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Eligibility Criteria
Inclusion
- History of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees withing the past 24 months
- Successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more
Exclusion
- Active ocular infection
- Clinically significant blepharitis
- Follicular conjunctivitis
- Pterygium
- Narrow angle glaucoma
- Dry eye dyndrome
- Ocular surgery within past 6 months
- Pregnancy or lactation
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00445874
Start Date
February 1 2007
End Date
May 1 2007
Last Update
April 9 2009
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85032
2
Phoenix, Arizona, United States
3
Irvine, California, United States
4
North Andover, Massachusetts, United States